DK0745093T3 - Hidtil ukendte oligopeptoder med affinitet til opioidreceptorer - Google Patents

Hidtil ukendte oligopeptoder med affinitet til opioidreceptorer

Info

Publication number
DK0745093T3
DK0745093T3 DK94901120T DK94901120T DK0745093T3 DK 0745093 T3 DK0745093 T3 DK 0745093T3 DK 94901120 T DK94901120 T DK 94901120T DK 94901120 T DK94901120 T DK 94901120T DK 0745093 T3 DK0745093 T3 DK 0745093T3
Authority
DK
Denmark
Prior art keywords
glu
gln
seq
pct
group
Prior art date
Application number
DK94901120T
Other languages
English (en)
Inventor
Linda Fryklund
Karin Ingeborg Fhoelenhag
Bo Christer Larsson
Fred Jarl Nyberg
Gertrud Elisab Westin-Sjoedahl
Ronny Lundin
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of DK0745093T3 publication Critical patent/DK0745093T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94901120T 1992-11-20 1993-11-18 Hidtil ukendte oligopeptoder med affinitet til opioidreceptorer DK0745093T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9203496A SE9203496D0 (sv) 1992-11-20 1992-11-20 New oligopeptides
PCT/SE1993/000986 WO1994012532A1 (en) 1992-11-20 1993-11-18 New oligopeptides with affinity to opioid receptors

Publications (1)

Publication Number Publication Date
DK0745093T3 true DK0745093T3 (da) 2002-05-13

Family

ID=20387887

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94901120T DK0745093T3 (da) 1992-11-20 1993-11-18 Hidtil ukendte oligopeptoder med affinitet til opioidreceptorer

Country Status (16)

Country Link
US (1) US5872097A (da)
EP (1) EP0745093B1 (da)
JP (1) JP3470136B2 (da)
AT (1) ATE212357T1 (da)
AU (1) AU684481B2 (da)
CA (1) CA2149899A1 (da)
DE (1) DE69331499T2 (da)
DK (1) DK0745093T3 (da)
ES (1) ES2171445T3 (da)
FI (1) FI952455A7 (da)
NO (1) NO313098B1 (da)
NZ (1) NZ258260A (da)
PT (1) PT745093E (da)
RU (1) RU2131438C1 (da)
SE (1) SE9203496D0 (da)
WO (1) WO1994012532A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1623801A (en) * 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
JP2008514612A (ja) * 2004-09-23 2008-05-08 ミシャロウ、アレクサンダー 対抗適応を誘発することにより神経伝達物質系を調節する方法
US7454406B2 (en) * 2005-04-29 2008-11-18 Adaptec, Inc. System and method of handling file metadata
US20160176930A1 (en) 2010-07-09 2016-06-23 The Administrators Of The Tulane Educational Fund Mu opioid receptor agonist analogs of the endomorphins
EP3246333B1 (en) * 2010-07-09 2020-10-07 The Administrators of The Tulane Educational Fund Mu opioid receptor agonist analogs of the endomorphins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2921216A1 (de) * 1979-05-25 1980-12-04 Teschemacher Hansjoerg Pharmakologisch aktive peptide
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
US4254024A (en) * 1979-10-16 1981-03-03 Pennwalt Corporation Tetrapeptides and derivatives having opiate activity
US4699897A (en) * 1983-06-04 1987-10-13 Amgen Biologically active peptides structurally related to regions within growth hormones
DE3333752A1 (de) * 1983-09-19 1985-04-11 Victor Dipl.- Chem. 8000 München Brantl Pharmakologisch aktive peptide
JP3130080B2 (ja) * 1990-12-27 2001-01-31 日清製粉株式会社 ペプチドおよびその製造方法

Also Published As

Publication number Publication date
NZ258260A (en) 1996-06-25
FI952455L (fi) 1995-05-19
EP0745093B1 (en) 2002-01-23
DE69331499D1 (de) 2002-03-14
RU2131438C1 (ru) 1999-06-10
RU95113498A (ru) 1997-03-20
US5872097A (en) 1999-02-16
FI952455A0 (fi) 1995-05-19
DE69331499T2 (de) 2002-08-08
NO951990L (no) 1995-05-19
ES2171445T3 (es) 2002-09-16
JPH08507748A (ja) 1996-08-20
FI952455A7 (fi) 1995-05-19
CA2149899A1 (en) 1994-06-09
NO313098B1 (no) 2002-08-12
AU5581694A (en) 1994-06-22
ATE212357T1 (de) 2002-02-15
JP3470136B2 (ja) 2003-11-25
AU684481B2 (en) 1997-12-18
PT745093E (pt) 2002-07-31
SE9203496D0 (sv) 1992-11-20
EP0745093A1 (en) 1996-12-04
NO951990D0 (no) 1995-05-19
WO1994012532A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
US4547489A (en) Conformationally restricted thymopentin-like compounds
Welply et al. Substrate recognition by oligosaccharyltransferase. Studies on glycosylation of modified Asn-X-Thr/Ser tripeptides.
Pierschbacher et al. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion.
FI92325B (fi) Menetelmä tymopentiinianalogien valmistamiseksi
KR940005670A (ko) 펩티드
Fernandez-Luna et al. Complete amino acid sequence of the Aspergillus cytotoxin mitogillin
ATE113063T1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
KR850001230A (ko) 옥타펩티드 바조프레신 길항물질의 제조방법
TW343198B (en) Cyclopeptides useful as adhesion inhibitors, process for the preparation thereof, and pharmaceutical composition containing them
CY1111740T1 (el) Συζευγματα πεπτιδιων ν- και/ή c-τελικως τροποποιημενα μεσω βραχεων αλυσων φορτισμενων πεπτιδιων
KR930007972A (ko) 환상 혈관활성 펩티드
ES2194861T3 (es) Peptidos opiodes.
DE69932424D1 (de) Melanocortin 1 rezeptorselektive verbindungen
DK0479912T3 (da) Fremgangsmåde til hæmning af N-endereglens forløb i levende celler
Sela et al. Studies on the chemical basis of the antigenicity of proteins. 3. The role of rigidity in the antigenicity of polypeptidyl gelatins
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
DK0745093T3 (da) Hidtil ukendte oligopeptoder med affinitet til opioidreceptorer
Kondo et al. Chemical and immunological properties and amino acid sequences of three lysozymes from Peking-duck egg white
US4652627A (en) Calcitonin analogs with C-terminal D-amino acid substituents
Bruschi et al. Non-heme iron proteins of Desulfovibrio: the primary structure of ferredoxin I from Desulfovibrio africanus
GB1516515A (en) Process for the preparation of insulin analogues and derivatives thereof
DE3151738C2 (da)
KR850006941A (ko) 데스-프로린 바조프레신 길항제의 제조방법
US4397842A (en) Peptides having thymopoietin-like activity
NZ335879A (en) Somatostatin antagonist peptides having a D-amino acid at the second residue